COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 187

Article download: 97

IP Indian Journal of Immunology and Respiratory Medicine


Role of corticosteroid as an adjunct to antitubercular drugs in the treatment of pleural effusion: A one year study


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Manoj Kumar Pandey, Santosh Kumar, Surya Kant*, Poornima Mishra

Volume : 4, Issue : 3, Year : 2019

Article Page : 170-175


Suggest article by email

Abstract

Background: To compare the effect of corticosteroid as an adjuvant to antitubercular treatment (ATT) in view of improving the symptoms, resolution of pleural fluid and prevention of pleural thickening.
A prospective case control study was conducted in the Department of Respiratory Medicine, King George’s Medical University, Lucknow, India.
Methodology: The present study has been conducted on 76 diagnosed cases of tubercular pleural effusion, 38 in case group and 38 in the control group. ATT was given to both the groups and steroid (prednisolone) was given to the case group as an adjuvant to ATT. Clinico-radiological follow-up has been done at the end of 1st, 2nd, 4th, and 6th month.
Results: The mean duration of resolution of fever, cough and breathlessness in case group was significantly less as compare to control group and their differences were statistically significant with p value < 0>nd month of treatment, after that the difference was not significant. At the end of 6th month, 35 patients developed pleural thickening, out of which 21 were of the control group while the remaining 14 were of the case group.
Conclusions: Use of corticosteroids as adjuvant to ATT resolve the clinical symptoms more quickly and hasten the absorption of pleural fluid and to some extent pleural thickening in patients with tubercular pleural effusion.

Keywords: Tubercular Pleural Effusion; Extrapulmonary tuberculosis (EPTB); Anti-tubercular treatment; Corticosteroid.

Doi : 10.18231/j.ijirm.2019.038

How to cite : Pandey M K, Kumar S, Kant S, Mishra P, Role of corticosteroid as an adjunct to antitubercular drugs in the treatment of pleural effusion: A one year study. IP Indian J Immunol Respir Med 2019;4(3):170-175

Copyright © 2019 by author(s) and IP Indian J Immunol Respir Med. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)